Boston Collaborative Drug Surveillance Program

475 papers and 23.7k indexed citations i.

About

In recent decades, authors affiliated with Boston Collaborative Drug Surveillance Program have published 475 papers, which have received a total of 23.7k indexed citations. Scholars at this organization have produced 60 papers in Surgery, 56 papers in Pharmacology and 55 papers in Epidemiology on the topics of Drug-Induced Adverse Reactions (26 papers), Estrogen and related hormone effects (25 papers) and Pharmaceutical studies and practices (24 papers). Their work is cited by papers focused on Surgery (3.9k citations), Molecular Biology (3.0k citations) and Pharmacology (2.8k citations). Authors at Boston Collaborative Drug Surveillance Program collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including New England Journal of Medicine, The Lancet and JAMA. Some of Boston Collaborative Drug Surveillance Program's most productive authors include Hershel Jick, Susan S. Jick, Christoph Meier, James A. Kaye, Christoph Meier, Raymond G. Schlienger, Laura E. Derby, Michael Bodmer, David J. Greenblatt and Russell R. Miller.

In The Last Decade

Fields of papers published by authors at Boston Collaborative Drug Surveillance Program

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Boston Collaborative Drug Surveillance Program at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Boston Collaborative Drug Surveillance Program at the time of their publication.

Countries citing scholars working at Boston Collaborative Drug Surveillance Program

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Boston Collaborative Drug Surveillance Program. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Boston Collaborative Drug Surveillance Program with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boston Collaborative Drug Surveillance Program more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025